Federal Circuit Says Teva’s Planned Parkinson’s Patch Infringes UCB Patent Under Doctrine of Equivalents – Lexology

Federal Circuit Says Teva’s Planned Parkinson’s Patch Infringes UCB Patent Under Doctrine of Equivalents  Lexology

In UCB Inc. v. Watson Laboratories, Inc., Nos. 2018-1397, -1453 (Fed. Cir. June 24, 2019), the Federal Circuit affirmed the district court’s decision holding UCB’s …